Propel Bio Management, LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$86.1B
Holdings
18
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (18 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PAGPPLAINS GP HOLDINGS LP-CL | 1,272,360 | $27.2B | 31.57% | |
| 2 | MDGLMADRIGAL PHARMACEUTICALS | 30,032 | $9.9B | 11.56% | |
| 3 | AKROAKERO THERAPEUTICS INC | 228,884 | $9.3B | 10.76% | |
| 4 | PHATPHATHOM PHARMACEUTICALS I | 1,134,927 | $7.1B | 8.27% | |
| 5 | SP4PACHIEVE LIFE SCIENCES INC | 2,453,092 | $6.5B | 7.61% | |
| 6 | APLTAPPLIED THERAPEUTICS INC | 11,285,420 | $5.5B | 6.41% | |
| 7 | RNAAVIDITY BIOSCIENCES INC | 178,500 | $5.3B | 6.12% | |
| 8 | ABEOABEONA THERAPEUTICS INC | 624,022 | $3.0B | 3.45% | |
| 9 | TCRXTSCAN THERAPEUTICS INC | 2,087,139 | $2.9B | 3.35% | |
| 10 | DCTHDELCATH SYSTEMS INC | 177,600 | $2.3B | 2.63% | |
| 11 | SNDXSYNDAX PHARMACEUTICALS IN | 183,259 | $2.3B | 2.62% | |
| 12 | ZVRAZEVRA THERAPEUTICS INC | 179,874 | $1.3B | 1.57% | |
| 13 | MISTMILESTONE PHARMACEUTICALS | 1,451,557 | $1.2B | 1.35% | |
| 14 | —MAAT PHARMA SACA | 166,423 | $1.0B | 1.21% | |
| 15 | CMPXCOMPASS THERAPEUTICS INC | 228,317 | $433.8M | 0.50% | |
| 16 | —ATHIRA PHARMA INC | 1,492,792 | $425.3M | 0.49% | |
| 17 | 72CEIGER BIOPHARMACEUTICALS | 146,381 | $423.0M | 0.49% | |
| 18 | —CHINOOK THERAPEUTICS | 79,357 | $38.5M | 0.04% |